A GM-CSF/CD40L producing cell augments anti-tumor T cell responses

Journal of Surgical Research

Volumn 125, Issue 2, 2005, Pages 173-181

  Dessureault, Sophie ^a   Alsarraj, Marwan ^a   McCarthy, Susan ^a   Hunter, Terri ^a   Noyes, David ^a   Lee, David ^a   Harkins, Jennifer ^a   Seigne, John ^a   Jennings, Ron ^a   Antonia, Scott J ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Autologous; Bystander; Cancer vaccine; CD40 ligand; GM CSF; Human; in vitro; Preclinical; Tumor immunology

Indexed keywords

CANCER VACCINE; CD40 LIGAND; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR;

ARTICLE; AUTOLOGOUS MIXED LYMPHOCYTE REACTION; BYSTANDER EFFECT; CANCER CELL CULTURE; CANCER IMMUNOTHERAPY; CANCER PATIENT; CONTROLLED STUDY; DENDRITIC CELL; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYPOTHESIS; LYMPH NODE CELL; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

EID: 20944447772     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jss.2004.11.036     Document Type: Article

References (38)

1. S.A. Rosenberg Identification of cancer antigens impact on development of cancer immunotherapies Cancer J. Sci. Am. 6 Suppl 3 2000 S200
2. M.J. Pittet, D. Valmori, P.R. Dunbar, D.E. Speiser, D. Lienard, F. Lejeune, K. Fleischhauer, V. Cerundolo, J.C. Cerottini, P. Romero High frequencies of naive Melan-A/MART-1-specific CD8(+) T cells in a large proportion of human histocompatibility leukocyte antigen (HLA)-A2 individuals J. Exp. Med. 190 1999 705
3. A. Anichini, A. Molla, R. Mortarini, G. Tragni, I. Bersani, M. Di Nicola, A.M. Gianni, S. Pilotti, R. Dunbar, V. Cerundolo, G. Parmiani An expanded peripheral T cell population to a cytotoxic T lymphocyte (CTL)-defined, melanocyte-specific antigen in metastatic melanoma patients impacts on generation of peptide-specific CTLs but does not overcome tumor escape from immune surveillance in metastatic lesions J. Exp. Med 190 1999 651
4. E. Jager, Y. Nagata, S. Gnjatic, H. Wada, E. Stockert, J. Karbach, P.R. Dunbar, S.Y. Lee, A. Jungbluth, D. Jager, M. Arand, G. Ritter, V. Cerundolo, B. Dupont, Y.T. Chen, L.J. Old, A. Knuth Monitoring CD8 T cell responses to NY-ESO-1 correlation of humoral and cellular immune responses Proc. Natl. Acad. Sci. U. S. A 97 2000 4760
5. D.M. Pardoll Cancer vaccines Nat. Med 4 1998 525
6. J. Banchereau, R.M. Steinman Dendritic cells and the control of immunity Nature 392 1998 245
7. D.I. Gabrilovich, H.L. Chen, K.R. Girgis, H.T. Cunningham, G.M. Meny, S. Nadaf, D. Kavanaugh, D.P. Carbone Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells Nat. Med 2 1996 1096
8. C. Menetrier-Caux, G. Montmain, M.C. Dieu, C. Bain, M.C. Favrot, C. Caux, J.Y. Blay Inhibition of the differentiation of dendritic cells from CD34(+) progenitors by tumor cells role of interleukin-6 and macrophage colony-stimulating factor Blood 92 1998 4778
9. Q. Chen, V. Daniel, D.W. Maher, P. Hersey Production of IL-10 by melanoma cells examination of its role in immunosuppression mediated by melanoma Int. J. Cancer 56 1994 755
10. D.R. Smith, S.L. Kunkel, M.D. Burdick, C.A. Wilke, M.B. Orringer, R.I. Whyte, R.M. Strieter Production of interleukin-10 by human bronchogenic carcinoma Am. J. Pathol 145 1994 18
11. M. Huang, J. Wang, P. Lee, S. Sharma, J.T. Mao, H. Meissner, K. Uyemura, R. Modlin, J. Wollman, S.M. Dubinett Human non-small cell lung cancer cells express a type 2 cytokine pattern Cancer Res 55 1995 384
12. K. Steinbrink, M. Wolfl, H. Jonuleit, J. Knop, A.H. Enk Induction of tolerance by IL-10-treated dendritic cells J. Immunol 159 1997 4772
13. F. Koch, U. Stanzl, P. Jennewein, K. Janke, C. Heufler, E. Kampgen, N. Romani, G. Schuler High level IL-12 production by murine dendritic cells upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10 J. Exp. Med 184 1996 741
14. K. Steinbrink, H. Jonuleit, G. Muller, G. Schuler, J. Knop, A.H. Enk Interleukin-10-treated human dendritic cells induce a melanoma-antigen-specific anergy in CD8(+) T cells resulting in a failure to lyse tumor cells Blood 93 1999 1634
15. G. Pirtskhalaishvili, G.V. Shurin, C. Esche, Q. Cai, R.R. Salup, S.N. Bykovskaia, M.T. Lotze, M.R. Shurin Cytokine-mediated protection of human dendritic cells from prostate cancer-induced apoptosis is regulated by the Bcl-2 family of proteins Br. J. Cancer 83 2000 506
16. C. Esche, G.V. Shurin, J.M. Kirkwood, G.Q. Wang, H. Rabinowich, G. Pirtskhalaishvili, M.R. Shurin Tumor necrosis factor-alpha-promoted expression of Bcl-2 and inhibition of mitochondrial cytochrome c release mediate resistance of mature dendritic cells to melanoma-induced apoptosis Clin. Cancer Res 7 2001 974
17. S.M. Kiertscher, J. Luo, S.M. Dubinett, M.D. Roth Tumors promote altered maturation and early apoptosis of monocyte-derived dendritic cells J. Immunol 164 2000 1269
18. J.W. Simons, E.M. Jaffee, C.E. Weber, H.I. Levitsky, W.G. Nelson, M.A. Carducci, A.J. Lazenby, L.K. Cohen, C.C. Finn, S.M. Clift, K.M. Hauda, L.A. Beck, K.M. Leiferman, A.H. Owens Jr., S. Piantadosi, G. Dranoff, R.C. Mulligan, D.M. Pardoll, F.F. Marshall Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer Cancer Res 57 1997 1537
19. A.E. Chang, Q. Li, D.K. Bishop, D.P. Normolle, B.D. Redman, B.J. Nickoloff Immunogenetic therapy of human melanoma utilizing autologous tumor cells transduced to secrete granulocyte-macrophage colony-stimulating factor Hum. Gene Ther 11 2000 839
20. J.W. Simons, B. Mikhak, J.F. Chang, A.M. DeMarzo, M.A. Carducci, M. Lim, C.E. Weber, A.A. Baccala, M.A. Goemann, S.M. Clift, D.G. Ando, H.I. Levitsky, L.K. Cohen, M.G. Sanda, R.C. Mulligan, A.W. Partin, H.B. Carter, S. Piantadosi, F.F. Marshall, W.G. Nelson Induction of immunity to prostate cancer antigens results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer Cancer Res 59 1999 5160
21. R. Soiffer, T. Lynch, M. Mihm, K. Jung, C. Rhuda, J.C. Schmollinger, F.S. Hodi, L. Liebster, P. Lam, S. Mentzer, S. Singer, K.K. Tanabe, A.B. Cosimi, R. Duda, A. Sober, A. Bhan, J. Daley, D. Neuberg, G. Parry, J. Rokovich, L. Richards, J. Drayer, A. Berns, S. Clift, G. Dranoff Vaccination with irradiated autologous melanoma cells engineered to secrete human granulocyte-macrophage colony-stimulating factor generates potent antitumor immunity in patients with metastatic melanoma Proc. Natl. Acad. Sci. U.S.A. 95 1998 13141
22. M. Kusumoto, S. Umeda, A. Ikubo, Y. Aoki, O. Tawfik, R. Oben, S. Williamson, W. Jewell, T. Suzuki Phase 1 clinical trial of irradiated autologous melanoma cells adenovirally transduced with human GM-CSF gene Cancer Immunol. Immunother 50 2001 373
23. E.M. Jaffee, R.H. Hruban, B. Biedrzycki, D. Laheru, K. Schepers, P.R. Sauter, M. Goemann, J. Coleman, L. Grochow, R.C. Donehower, K.D. Lillemoe, S. O'Reilly, R.A. Abrams, D.M. Pardoll, J.L. Cameron, C.J. Yeo Novel allogeneic granulocyte-macrophage colony-stimulating factor-secreting tumor vaccine for pancreatic cancer a phase I trial of safety and immune activation J. Clin. Oncol 19 2001 145
24. I. Borrello, E.M. Sotomayor, S. Cooke, H.I. Levitsky A universal granulocyte-macrophage colony-stimulating factor-producing bystander cell line for use in the formulation of autologous tumor cell-based vaccines Hum. Gene Ther 10 1999 1983
25. N. Mach, G. Dranoff Cytokine-secreting tumor cell vaccines Curr. Opin. Immunol 12 2000 571
26. W.G. Nelson, J.W. Simons, B. Mikhak, J.F. Chang, A.M. DeMarzo, M.A. Carducci, M. Kim, C.E. Weber, A.A. Baccala, M.A. Goeman, S.M. Clift, D.G. Ando, H.I. Levitsky, L.K. Cohen, M.G. Sanda, R.C. Mulligan, A.W. Partin, H.B. Carter, S. Piantadosi, F.F. Marshall Cancer cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer as vaccines for the treatment of genitourinary malignancies Cancer Chemother. Pharmacol 46 2000 S67
27. C. Chiodoni, P. Paglia, A. Stoppacciaro, M. Rodolfo, M. Parenza, M.P. Colombo Dendritic cells infiltrating tumors cotransduced with granulocyte/macrophage colony-stimulating factor (GM-CSF) and CD40 ligand genes take up and present endogenous tumor-associated antigens, and prime naive mice for a cytotoxic T lymphocyte response J. Exp. Med 190 1999 125
28. M. Cella, D. Scheidegger, K. Palmer-Lehmann, P. Lane, A. Lanzavecchia, G. Alber Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity T-T help via APC activation J. Exp. Med 184 1996 747
29. J. Peguet-Navarro, C. Dalbiez-Gauthier, F.M. Rattis, C. Van Kooten, J. Banchereau, D. Schmitt Functional expression of CD40 antigen on human epidermal Langerhans cells J. Immunol 155 1995 4241
30. C. Caux, C. Massacrier, B. Vanbervliet, B. Dubois, C. Van Kooten, I. Durand, J. Banchereau Activation of human dendritic cells through CD40 cross-linking J. Exp. Med 180 1994 1263
31. G. Dotti, B. Savoldo, P. Yotnda, D. Rill, M.K. Brenner Transgenic expression of CD40 ligand produces an in vivo antitumor immune response against both CD40(+) and CD40(-) plasmacytoma cells Blood 100 2002 200
32. E.M. Sotomayor, I. Borrello, E. Tubb, F.M. Rattis, H. Bien, Z. Lu, S. Fein, S. Schoenberger, H.I. Levitsky Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40 Nat. Med 5 1999 780
33. L.C. Andersson, K. Nilsson, C.G. Gahmberg K562-a human erythroleukemic cell line Int. J. Cancer 23 1979 143
34. S. Dessureault, F.L. Graham, S. Gallinger Autologous lymphocyte responses to adenovirus-B7-1-transduced human cancer cells Cancer Gene Ther 6 1999 195
35. E.M. Jaffee, M.C. Thomas, A.Y. Huang, K.M. Hauda, H.I. Levitsky, D.M. Pardoll Enhanced immune priming with spatial distribution of paracrine cytokine vaccines J. Immunother. Emphasis Tumor Immunol 19 1996 176
36. I.E. Flesch, D. Stober, R. Schirmbeck, J. Reimann Monocyte inflammatory protein-1 alpha facilitates priming of CD8(+) T cell responses to exogenous viral antigen Int. Immunol 12 2000 1365
37. P. Brossart, A. Zobywalski, F. Grunebach, L. Behnke, G. Stuhler, V.L. Reichardt, L. Kanz, W. Brugger Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells Cancer Res 60 2000 4485
38. C. Esche, A. Gambotto, Y. Satoh, V. Gerein, P.D. Robbins, S.C. Watkins, M.T. Lotze, M.R. Shurin CD154 inhibits tumor-induced apoptosis in dendritic cells and tumor growth Eur. J. Immunol 29 1999 2148